+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theranostics Market by Product Type (Diagnostic Agents, Therapeutic Agents), Technology (Biomarker-Based Theranostics, Companion Diagnostics (CDx), Gene Therapy-Based Theranostics), Application Area, End-User - Global Forecast 2025-2030- Product Image
Theranostics Market by Product Type (Diagnostic Agents, Therapeutic Agents), Technology (Biomarker-Based Theranostics, Companion Diagnostics (CDx), Gene Therapy-Based Theranostics), Application Area, End-User - Global Forecast 2025-2030- Product Image
Sale

Theranostics Market by Product Type (Diagnostic Agents, Therapeutic Agents), Technology (Biomarker-Based Theranostics, Companion Diagnostics (CDx), Gene Therapy-Based Theranostics), Application Area, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083045
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The theranostics market is advancing rapidly, propelled by the integration of diagnostic precision and targeted therapeutics to support next-generation personalized medicine. This sector is reshaping patient care by optimizing treatment outcomes, accelerating clinical timelines, and allowing adaptable, real-time interventions through innovation and collaboration among global stakeholders.

Market Snapshot: Theranostics Market Size and Growth

The Theranostics Market grew from USD 2.93 billion in 2024 to USD 3.32 billion in 2025. It is expected to continue growing at a CAGR of 13.72%, reaching USD 6.34 billion by 2030. This strong growth trajectory reflects heightened demand for solutions that couple disease detection with tailored therapies, supporting a shift toward precision and value-based healthcare delivery models.

Scope & Segmentation of the Theranostics Market

This analysis covers a comprehensive array of market segments, technology areas, applications, end-users, regional territories, and competitive players.

  • Product Types: Diagnostic agents, therapeutic agents.
  • Technologies: Biomarker-based theranostics, companion diagnostics (CDx), gene therapy-based approaches, molecular imaging, nanotechnology, radiopharmaceutical solutions, targeted drug delivery.
  • Application Areas: Oncology (including breast, lung, neuroendocrine, prostate, and thyroid cancers), autoimmune, cardiovascular, infectious, inflammatory, metabolic, and neurological disorders.
  • End-Users: Diagnostic imaging centers, hospitals and cancer care centers, research and academic institutes, specialty clinics.
  • Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including UK, Germany, France, UAE, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, and others).
  • Key Companies: Actinium Pharmaceuticals, Astellas Pharma, Bayer AG, bioMérieux, Cardinal Health, Clarity Pharmaceuticals, Curium Inc., GE HealthCare Technologies, Siemens Healthineers, Telix Pharmaceuticals, and more.

Key Takeaways for Decision-Makers

  • The fusion of diagnostic and therapeutic platforms positions theranostics at the forefront of personalized medicine, supporting more accurate treatment selection and improved patient outcomes across multiple disease categories.
  • Ongoing advancements in nanotechnology, gene editing, and molecular imaging are broadening the scope of targeted interventions, streamlining workflows, and promoting the development of next-generation delivery systems.
  • Collaboration between pharma, biotech, and diagnostic sectors enables faster innovation cycles, accelerates validation of novel biomarkers, and shortens time-to-market for advanced solutions.
  • Adaptation to region-specific regulations and infrastructure is essential, as markets in the Americas, Europe, and Asia-Pacific each present distinct opportunities and challenges for market entry and growth.
  • Patient-centric features such as remote monitoring and adaptive regimens are influencing demand, making digital integration and workflow flexibility key priorities for providers and manufacturers alike.
  • Leading players continue to diversify through mergers, acquisitions, and technology partnerships, fostering a highly competitive landscape that rewards agility and cross-sector collaboration.

Tariff Impact on Supply Chains and Market Accessibility

Recent tariff adjustments in major markets are reshaping global supply chains for theranostics products, prompting firms to reconsider sourcing strategies and invest in domestic production capabilities. Cost increases for key components and reagents are leading to intensified in-house manufacturing efforts, with industry players leveraging collaborative procurement and resource sharing to mitigate financial impacts. This climate places added importance on local capacity building, particularly for regions reliant on imported imaging or radiopharmaceutical materials.

Methodology & Data Sources

The research is grounded in extensive primary interviews with executives, clinical experts, and supply chain specialists, complemented by secondary analysis of peer-reviewed journals, regulatory documents, and industry reports. Quantitative findings are substantiated through triangulation with financial filings and clinical trial databases to ensure robust, actionable insights.

Why This Report Matters

  • Guides strategic planning by highlighting pivotal market trends, key innovation drivers, and sector-specific competitive movements.
  • Delivers actionable intelligence for navigating regulatory shifts and emerging economic pressures, such as tariff-induced supply chain changes.
  • Enables targeted opportunity evaluation through detailed segmentation and regional analysis, supporting informed allocation of investment and resources.

Conclusion

The theranostics market, anchored by integrated diagnostic-therapeutic innovation, is poised to redefine precision medicine globally. Stakeholders equipped with timely intelligence and adaptive strategies can secure lasting competitive positioning and capitalize on expanding growth opportunities.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of personalized medicine driving theranostics demand
5.2. Growing integration of diagnostics and therapeutics in oncology treatment
5.3. Advancements in radiopharmaceuticals enhancing theranostic effectiveness
5.4. Rising prevalence of chronic diseases fueling precision treatment approaches
5.5. Technological innovations in molecular imaging and targeted therapy
5.6. Expanding applications of theranostics beyond oncology into cardiology and neurology
5.7. Strategic collaborations between pharma and diagnostic companies accelerating innovation
5.8. Regulatory support and streamlined approval processes boosting market growth
5.9. Growing patient demand for minimally invasive and targeted treatment solutions
5.10. Emergence of artificial intelligence in improving theranostic accuracy and outcomes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Theranostics Market, by Product Type
8.1. Introduction
8.2. Diagnostic Agents
8.3. Therapeutic Agents
9. Theranostics Market, by Technology
9.1. Introduction
9.2. Biomarker-Based Theranostics
9.3. Companion Diagnostics (CDx)
9.4. Gene Therapy-Based Theranostics
9.5. Molecular Imaging
9.6. Nanotechnology-Based Theranostics
9.7. Radiopharmaceutical-Based Theranostics
9.8. Targeted Drug Delivery
10. Theranostics Market, by Application Area
10.1. Introduction
10.2. Autoimmune Disorders
10.3. Cardiovascular Diseases
10.4. Infectious Diseases
10.5. Inflammatory Diseases
10.6. Metabolic Disorders
10.7. Neurological Disorders
10.8. Oncology
10.8.1. Breast Cancer
10.8.2. Lung Cancer
10.8.3. Neuroendocrine Tumors
10.8.4. Prostate Cancer
10.8.5. Thyroid Cancer
11. Theranostics Market, by End-User
11.1. Introduction
11.2. Diagnostic Imaging Centers
11.3. Hospitals & Cancer Care Centers
11.4. Research & Academic Institutes
11.5. Specialty Clinics
12. Americas Theranostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Theranostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Theranostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Actinium Pharmaceuticals, Inc.
15.3.2. Ariceum Therapeutics GmbH
15.3.3. Astellas Pharma Inc.
15.3.4. BAMF Health
15.3.5. Bayer AG
15.3.6. bioMérieux SA
15.3.7. Biosynth Ltd.
15.3.8. Cardinal Health, Inc.
15.3.9. Cerebral Therapeutics, Inc.
15.3.10. Clarity Pharmaceuticals
15.3.11. Curasight A/S
15.3.12. Curium Inc.
15.3.13. Evergreen Theragnostics, Inc.
15.3.14. GE HealthCare Technologies, Inc.
15.3.15. Hermes Medical Solutions AB
15.3.16. Icon Group
15.3.17. Indi Molecular, Inc.
15.3.18. Integrated Clinical Oncology Network Pty Ltd.
15.3.19. Radiopharm Theranostics Limited
15.3.20. Ratio Therapeutics
15.3.21. Siemens Healthineers AG
15.3.22. SOFIE Co.
15.3.23. Telix Pharmaceuticals Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. THERANOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL THERANOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. THERANOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. THERANOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. THERANOSTICS MARKET: RESEARCHAI
FIGURE 24. THERANOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. THERANOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. THERANOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. THERANOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL THERANOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL THERANOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL THERANOSTICS MARKET SIZE, BY BIOMARKER-BASED THERANOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL THERANOSTICS MARKET SIZE, BY BIOMARKER-BASED THERANOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL THERANOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS (CDX), BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL THERANOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS (CDX), BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL THERANOSTICS MARKET SIZE, BY GENE THERAPY-BASED THERANOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL THERANOSTICS MARKET SIZE, BY GENE THERAPY-BASED THERANOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL THERANOSTICS MARKET SIZE, BY NANOTECHNOLOGY-BASED THERANOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL THERANOSTICS MARKET SIZE, BY NANOTECHNOLOGY-BASED THERANOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICAL-BASED THERANOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICAL-BASED THERANOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL THERANOSTICS MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL THERANOSTICS MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL THERANOSTICS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL THERANOSTICS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL THERANOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL THERANOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL THERANOSTICS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL THERANOSTICS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL THERANOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL THERANOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL THERANOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL THERANOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL THERANOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL THERANOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL THERANOSTICS MARKET SIZE, BY THYROID CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL THERANOSTICS MARKET SIZE, BY THYROID CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS & CANCER CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS & CANCER CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL THERANOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL THERANOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. CANADA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 98. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 99. CANADA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 100. CANADA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 101. CANADA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 102. CANADA THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 103. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 106. MEXICO THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 107. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 108. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 109. MEXICO THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 110. MEXICO THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 111. MEXICO THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 112. MEXICO THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 155. GERMANY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. GERMANY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. GERMANY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. GERMANY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. GERMANY THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 160. GERMANY THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 161. GERMANY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 162. GERMANY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 163. GERMANY THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 165. FRANCE THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. FRANCE THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. FRANCE THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. FRANCE THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. FRANCE THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 170. FRANCE THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 171. FRANCE THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 172. FRANCE THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 173. FRANCE THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 174. FRANCE THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 185. ITALY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. ITALY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. ITALY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. ITALY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. ITALY THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 190. ITALY THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 191. ITALY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 192. ITALY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 193. ITALY THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 194. ITALY THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 195. SPAIN THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. SPAIN THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. SPAIN THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. SPAIN THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. SPAIN THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 200. SPAIN THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 201. SPAIN THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 202. SPAIN THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 203. SPAIN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 204. SPAIN THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 220. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 222. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 224. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 230. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 234. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 235. DENMARK THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. DENMARK THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. DENMARK THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. DENMARK THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. DENMARK THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 240. DENMARK THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 241. DENMARK THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 242. DENMARK THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 243. DENMARK THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 244. DENMARK THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 245. NETHERLANDS THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. NETHERLANDS THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. NETHERLANDS THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. NETHERLANDS THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. NETHERLANDS THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 250. NETHERLANDS THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 251. NETHERLANDS THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 252. NETHERLANDS THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 253. NETHERLANDS THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 254. NETHERLANDS THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 255. QATAR THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. QATAR THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. QATAR THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. QATAR THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. QATAR THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 260. QATAR THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 261. QATAR THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 262. QATAR THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 263. QATAR THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 264. QATAR THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 265. FINLAND THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. FINLAND THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. FINLAND THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. FINLAND THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. FINLAND THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 270. FINLAND THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 271. FINLAND THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 272. FINLAND THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 273. FINLAND THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 274. FINLAND THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 275. SWEDEN THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. SWEDEN THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. SWEDEN THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. SWEDEN THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. SWEDEN THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 280. SWEDEN THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 281. SWEDEN THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 282. SWEDEN THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 283. SWEDEN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 284. SWEDEN THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 285. NIGERIA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. NIGERIA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. NIGERIA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. NIGERIA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. NIGERIA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 290. NIGERIA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 291. NIGERIA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 292. NIGERIA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 293. NIGERIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 294. NIGERIA THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 295. EGYPT THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. EGYPT THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. EGYPT THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. EGYPT THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. EGYPT THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 300. EGYPT THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 301. EGYPT THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 302. EGYPT THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 303. EGYPT THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 304. EGYPT THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 305. TURKEY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. TURKEY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. TURKEY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. TURKEY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. TURKEY THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 310. TURKEY THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 311. TURKEY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 312. TURKEY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 313. TURKEY THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 314. TURKEY THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 315. ISRAEL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. ISRAEL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. ISRAEL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. ISRAEL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. ISRAEL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 320. ISRAEL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 321. ISRAEL THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 322. ISRAEL THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 323. ISRAEL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 324. ISRAEL THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 325. NORWAY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. NORWAY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. NORWAY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 328. NORWAY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 329. NORWAY THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 330. NORWAY THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 331. NORWAY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 332. NORWAY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 333. NORWAY THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 334. NORWAY THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 335. POLAND THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. POLAND THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. POLAND THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 338. POLAND THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 339. POLAND THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 340. POLAND THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 341. POLAND THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 342. POLAND THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 343. POLAND THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 344. POLAND THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 345. SWITZERLAND THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. SWITZERLAND THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 347. SWITZERLAND THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 348. SWITZERLAND THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 349. SWITZERLAND THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 350. SWITZERLAND THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 351. SWITZERLAND THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 352. SWITZERLAND THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 353. SWITZERLAND THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 354. SWITZERLAND THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 355. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 356. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 357. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 358. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 359. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 360. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 361. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 362. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 363. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 364. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 365. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 366. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 367. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 368. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 369. CHINA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 370. CHINA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Theranostics market report include:
  • Actinium Pharmaceuticals, Inc.
  • Ariceum Therapeutics GmbH
  • Astellas Pharma Inc.
  • BAMF Health
  • Bayer AG
  • bioMérieux SA
  • Biosynth Ltd.
  • Cardinal Health, Inc.
  • Cerebral Therapeutics, Inc.
  • Clarity Pharmaceuticals
  • Curasight A/S
  • Curium Inc.
  • Evergreen Theragnostics, Inc.
  • GE HealthCare Technologies, Inc.
  • Hermes Medical Solutions AB
  • Icon Group
  • Indi Molecular, Inc.
  • Integrated Clinical Oncology Network Pty Ltd.
  • Radiopharm Theranostics Limited
  • Ratio Therapeutics
  • Siemens Healthineers AG
  • SOFIE Co.
  • Telix Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.34 Billion
Compound Annual Growth Rate13.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Theranostics - Global Strategic Business Report - Product Image

Theranostics - Global Strategic Business Report

  • Report
  • 472 Pages
  • Global
From
Theranostics Market Report 2025 - Product Image

Theranostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report 2025 - Product Image

Radiopharmaceutical Theranostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cell & Gene Therapy Market by Therapy Type (Cell Therapy, Gene Therapy), Delivery Method (Intramuscular, Intravenous), Therapeutic Areas, Application, End User - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Market by Therapy Type (Cell Therapy, Gene Therapy), Delivery Method (Intramuscular, Intravenous), Therapeutic Areas, Application, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From

About the Theranostics Market

Theranostics is a field of medicine that combines diagnostics and therapeutics to provide personalized treatments for patients. It is closely related to genomics, which is the study of an individual's genetic makeup. Theranostics uses genomic information to identify the best treatment for a patient, based on their unique genetic profile. This approach is becoming increasingly popular as it allows for more precise and effective treatments. Theranostics is used in a variety of medical fields, including oncology, neurology, and cardiology. It is also being used to develop new treatments for rare diseases. By combining genomic data with other medical information, such as imaging and laboratory tests, doctors can better understand a patient's condition and develop more effective treatments. Some companies in the Theranostics market include Illumina, Thermo Fisher Scientific, and Qiagen. These companies provide products and services related to genomics, such as DNA sequencing, gene expression analysis, and bioinformatics. They also offer products and services related to theranostics, such as biomarker discovery and drug development. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.